Skip to content

Acupoint hot compress with fennel kosher salt for treatment of intestinal adverse reactions of myeloablative chemotherapy: a randomized controlled trial

Study on gastrointestinal adverse reactions associated with myelopathic chemotherapy treated by Netopitam-palonosetron combined with fennel kosher salt acupoint hot compress

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093323
Enrollment
Unknown
Registered
2024-12-02
Start date
2024-12-02
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological system diseases

Interventions

experimental group:On the basis of conventional Western medicine treatment, add fennel kosher salt hot compress operation
control group:Netopitampalonosetron capsule commonly used in clinic was used

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: According to the Guidelines for the Diagnosis and Treatment of Common Malignant Tumors of the Chinese Society of Clinical Oncology (CSCO), the diagnosis of hematological malignancy was confirmed by histopathological or cytological examination; All patients received chemotherapy; Volunteer to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: Allergic to fennel; Heat intolerance; Skin inflammation and skin ulceration at the hot compress site; There are mental disorders can not cooperate. Patients with severe heart, brain, vascular diseases, gastrointestinal hemorrhage or intestinal obstruction.

Design outcomes

Primary

MeasureTime frame
Occurrence and severity of nausea and vomiting;

Secondary

MeasureTime frame
TCM symptom score;Patient's self-care ability;

Countries

China

Contacts

Public ContactWu Qiuhui

West China Hospital, Sichuan University

qiuhui3574@163.com+86 189 8060 5063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026